Study identifier:D3461R00092
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An observational multicenter retrospective-prospective study of patients with active moderate to severe SLE
Systemic Lupus Erythematosus
N/A
No
-
All
600
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|